# 1. Financial Performance ## A. Key Figures * **Total Revenue (Consolidated):** **₹484 Cr** FY26 (+12.3% YoY) * **Operating Revenue (Consolidated):** **₹482 Cr** FY26 (+13.4% YoY) * **Operating Revenue (Standalone):** **₹446 Cr** FY26 (+15.8% YoY) · **₹138 Cr** Q4 (+21% YoY) * **COGS (% of Op. Rev):** **40%** Consolidated (vs. 42% YoY) · **41%** Standalone (vs. 42% YoY) * **Employee Costs (% of Op. Rev):** **23%** Consolidated (vs. 21% YoY) · **19%** Standalone (vs. 18% YoY) ## B. Revenue & Growth Drivers * **Sustained Top-line Momentum:** Achieved a four-year consistent upward trend in standalone revenue, with recent quarterly growth primarily fueled by robust volume increases. * **Pricing Strategy:** Implemented a strategic surcharge to mitigate rising input costs and depreciation related to geopolitical issues in Iran, successfully protecting the bottom line. * **Core Business Strength:** Standalone profitability continues to be anchored by the core coding and marking segment, which maintains high gross margin benchmarks for the group. ## C. Cost Structure & Operational Efficiency * **Regulatory Headwinds:** Employee benefit expenses saw a sharp uptick due to the **November 2025** new wage code implementation, resulting in a **₹3.5 Cr** impact from recast leave and gratuity liabilities. * **International Rightsizing:** Management has restructured international offices, eliminating non-productive roles and dismissing **3-4 personnel** to pivot resources toward high-output sales teams. * **Incentive Alignment:** Increased personnel costs reflect new provisions for sales/service incentives and loyalty bonuses aimed at retaining key management talent. * **Tax Optimization:** With the consolidated tax rate nearing **40%**, the company is evaluating a cost restructuring plan to shift specific operations to India. ## D. Subsidiary & International Impact * **Italian Subsidiary Drag:** CP Italy accounts for the entirety of consolidated losses outside India; the unit faces high R&D expensing of **€100,000 per month** and quality control testing delays. * **V-Shapes Challenges:** Performance hampered by design changes and logistical bottlenecks in the Strait of Hormuz; future funding is strictly earmarked for loan servicing rather than operations. * **Strategic Scaling:** Directed CODEOLOGY to downsize to a **$1M–$1.5M** range to eliminate excess costs, while MARKPRINT is poised for growth following marquee contract wins. * **Capital Incentives:** Expansion projects are eligible for a capital subsidy capped at **₹7.5 Cr**, a **5%** interest subsidy for six years, and a GST refund linked to total plant investment. * **Capital Outlay:** Management is deploying an additional **₹32 Cr** into the Italian subsidiary via IPR or equity, despite investor concerns regarding the timeline for break-even. --- # 2. Operating Segments & Mix ## A. Key Figures * **Revenue Mix (FY25-26):** **14%** Printers · **61%** Consumables · **9%** Spares · **15%** Services * **Revenue Mix (Q4):** **12%** Printers · **62%** Consumables · **9%** Spares · **16%** Services ## B. Coding & Marking * **Core Profit Engine:** Remains the primary cash flow driver with market leadership in cement, dairy, and sugar; industrial verticals (cables/steel) show higher volatility tied to construction cycles. * **Strategic Expansion:** Entering the "print and apply" segment to secure future recurring revenue; first product readings conducted in **April 2026** with sales expected this fiscal year. * **Growth Outlook:** Management is pursuing new technologies to move beyond "comfortable growth," though core India operations maintain encouraging printer sales metrics. ## C. Track & Trace * **Financial Inflection:** Segment has reached a critical breakeven point and is now expected to be a neutral-to-positive contributor to consolidated profitability. * **Value Proposition:** Shifting focus toward **IP-differentiated solutions** offering **100% accuracy** for anti-counterfeiting, supply chain logistics, and diversion tracking. * **Market Integration:** Outlook is bolstered by expansion into core activities within the packaging division and the acquisition of new customers. ## D. Packaging & V-Shapes * **High-Upside Investment:** Management views the packaging sector as having significantly larger scale than core coding, justifying ongoing investment despite technical stabilization hurdles. * **V-Shapes Dual Model:** Italian operations utilize a hybrid "technology development + contract packaging" model, allowing clients to market-test **50,000 to 100,000 units** before hardware commitment. * **Geographic Strategy:** Indian entity manages APAC and MEA (currently **90%** focused on India/Gulf), while CODEOLOGY pivots to V-Shapes sales in the UK and Scandinavia. ## E. Revenue Stream Mix * **Annuity-Driven Model:** Business utilizes a "jet engine" strategy where hardware sales facilitate long-term high-margin recurring revenue from materials over a **10 to 12-year** equipment lifespan. * **Installation Velocity:** Non-core business segments are projected to maintain a steady installation growth rate of approximately **25% per year**. * **Consumables Dominance:** The revenue profile remains heavily weighted toward high-margin consumables and services, which together account for over three-quarters of the total mix. --- # 3. Manufacturing & Supply Chain ## A. Key Figures * **Historical Royalties:** **₹100 Cr – ₹150 Cr** paid over 20 years (now declining) ## B. Guwahati Facility Expansion * **Strategic Hub:** Establishing a new unit in Guwahati linked to the packaging segment and V-Shapes IP to address high material costs. * **Incentive-Driven Location:** Site selection prioritized over Mumbai or Silvassa to leverage existing regional experience and **UNNATI scheme incentives**. * **Growth Catalyst:** The facility aims to drive exponential volume growth by lowering cost barriers during the early stages of the V-Shapes business. ## C. Production Standardization * **Operational Rigor:** Implementing standardized manufacturing protocols and stricter compliance to move away from inconsistent, custom-built production methods. * **Quality Control Delays:** Shipments are intentionally paused to ensure machines meet "one-day installation" standards and identical design specifications across the first **10 initial units**. * **BOM Management:** Addressing critical challenges in the **Bill of Materials (BOM)** workflow where outdated drawings previously led to non-functional parts. * **Supply Chain Shift:** Plans to transition from local Italian suppliers to internal manufacturing or proprietary sourcing once designs are finalized. ## D. Inventory & Logistics * **Risk Mitigation:** Maintaining elevated stock levels and a persistent **customer surcharge** to offset supply chain volatility and rising expenses. * **Revenue Conversion:** Current factory-held inventory is expected to convert into cash flow and recurring revenue immediately upon the shipment of finalized machines. * **Freight Dynamics:** Logistics costs from the Northeast are partially offset by **minor freight subsidies** for transport to regions like Bengal. --- # 4. Technology & IP Strategy ## A. Key Figures * **Royalty Savings:** **₹7 Cr – ₹10 Cr** annual license fees eliminated via IP ownership * **Portfolio Mix:** **40%** in-house solutions · **60%** licensed CIJ technology (down from **90%**) ## B. Proprietary IP Development * **Strategic Pivot to Ownership:** Management is aggressively transitioning from a distribution/licensing model to a proprietary IP-stack, aiming to emulate high-value global tech firms. * **Long-term Protection:** Secured patents for new "Snap" powder technology, extending IP protection through **2044**. * **Platform Monetization:** Evaluating a platform-based model for newly acquired packaging IP, including internal manufacturing or global third-party licensing. * **Value Creation:** The acquired packaging IP is projected to eventually surpass the core coding business in both scale and profitability. ## C. R&D Expenditure * **Sustained Innovation:** A decade-long commitment to internal R&D has culminated in a robust tech team capable of building complex, proprietary platforms. * **Resource Allocation:** R&D spend includes internal staffing and specialized external consultants to drive technical testing for the Italian unit. * **Segment Maturity:** Reflects a multi-year investment cycle, with **four to five years** dedicated specifically to maturing the Track and Trace and packaging segments. ## D. Product Portfolio Evolution * **Diversification Beyond Coding:** Strategic expansion into digital printing and PPE; the Mask Lab has evolved into a comprehensive safety division trading various industrial gear. * **In-House Transition:** Successfully reduced reliance on external CIJ licenses by increasing the share of proprietary solutions in the sales mix. * **Operational Discipline:** Finalizing a new machine model with a **10-unit** pilot batch to ensure performance stability before mass production. ## E. M&A Integration * **Targeted Acquisitions:** Utilized Codeology and Markprint to bridge portfolio gaps in print-and-apply and digital printing, creating a hybrid solution ecosystem. * **Technology Transfer:** Successfully integrated blockchain-based Track and Trace (via QRiouscodes) and transferred print engine technology from UK-based Codeology. * **Manufacturing Rigor:** Transitioning acquired R&D-heavy outfits toward "first-time-right" manufacturing disciplines to improve field reliability. --- # 5. Customer & Market Metrics ## A. Key Figures * **Printer Sales Volume:** **3,064 units** FY26 total * **Track & Trace Market Size:** **₹500 Cr – ₹600 Cr** estimated ## B. Printer Sales & Operations * **Order Book Backlog:** Significant demand for the latest CP Italy machine batch remains unfulfilled as the company prioritizes refined testing protocols. * **Revenue Timing:** Optical growth at CP Italy was dampened by shipping delays of units already sold, indicating a timing-related revenue lag. * **Volume Performance:** Robust annual printer sales achieved, supported by a consistent track record of operational execution. ## C. Pharmaceutical Pilot Programs * **Strategic Proof of Concept:** Finalizing high-stakes pilots with two of India’s top pharmaceutical majors to demonstrate performance superiority over existing solutions. * **Scalability Potential:** Successful conclusion of current market testing is expected to trigger larger rollouts and broader industry adoption. * **Market Validation:** Management encourages direct customer verification of their value proposition to validate the technical shift they are leading in the sector. ## D. Competitive Positioning & Strategy * **Differentiated Entry:** Despite being a late entrant in Track and Trace, the strategy focuses on high-end technical differentiation rather than mass-market volume. * **Disruptive Ambitions:** Management aims to re-establish industry standards, shifting market dynamics to drive proactive customer pull for their services. * **Targeted Segments:** Investing in materials to capture the **INR 10 packet** market, targeting a price point of **INR 1.20 to INR 1.30** for bulk customers. * **Investor Sentiment:** Management acknowledged concerns regarding PE compression and market cap, reiterating their **6 to 8-year** history of dividends and buybacks. --- # 6. Risks & Operational Challenges ## A. Geopolitical & Supply Chain Pressures * **Macro Headwinds:** Significant cost pressures emerging from **rupee depreciation** and chemical supply chain disruptions linked to geopolitical conflicts in **Iran**. * **Input Inflation:** Packaging costs have seen a **25% increase** due to geopolitical factors affecting critical imports. ## B. Subsidiary Performance & Technical Risks * **Loss Concentration:** Financial drag is almost exclusively tied to the **packaging division abroad (CP Italy)** and **V-Shapes**, driven by an elongated investment cycle. * **Restoration Delays:** The acquisition of the packaging business from liquidation involved unforeseen **technical and quality damage**, requiring more extensive restoration than budgeted. * **Operational Stabilization:** Initial machine units are facing consistency issues, necessitating multiple engineering interventions and **unit replacements** from internal stock to meet standards. * **Delivery Bottlenecks:** Timely deliveries were hampered by **changes in machine specifications**, though management is prioritizing technical excellence over speed to market. ## C. Product Security & Integrity * **Systemic Security Flaws:** Current pharmaceutical track-and-trace systems face a critical vulnerability where **QR codes** can be replicated across counterfeit batches, misleading consumers. * **Strategic Focus:** Control Print is actively developing solutions to address the industry-wide failure where **counterfeit medicines are incorrectly authenticated**, posing a risk to consumer safety. --- # 7. Guidance & Outlook ## A. Key Figures * **Subsidiary Growth Target:** **15% to 20%** top-line growth for CODEOLOGY and MARKPRINT * **Regulatory Scope:** Potential expansion from **300** to **946** specific medications ## B. Top-line Growth Targets * **Scaling Catalysts:** Successful completion of ongoing pilots is expected to trigger firm scaling commitments, serving as a primary growth driver for the current fiscal. * **Subsidiary Momentum:** Management projects robust double-digit growth for international subsidiaries, though they maintain a conservative stance on providing long-term revenue mix projections for new segments. ## C. Breakeven Timelines * **Path to Profitability:** The V-Shapes segment is positioned to potentially break even this year following a drastic reduction in year-over-year losses. * **Self-Sustaining Ventures:** QRiousCodes has reached a financial inflection point, achieving breakeven and requiring no further capital infusions for development. * **Capital Discipline:** Leadership is actively monitoring milestones to prevent open-ended investments, with no further capital expected for V-Shapes once India technology transfers are finalized. ## D. Regulatory Mandate Expectations * **Pharma Expansion:** While official notifications are pending, discussions with the DCGI suggest a significant widening of track and trace mandates to cover nearly **1,000 medications**. * **Industrial Stability:** Demand for coding in the pipes and cables sector is secured by stable government legislation regarding mandatory marking (MRP, batch, pressure ratings) for the next several years. ## E. Long-term Strategic Vision * **IP-Led Strategy:** The company is intentionally prioritizing the development of highly differentiated Intellectual Property over short-term gains, accepting a period of muted growth to secure a **10-20 year** sustainable platform. * **Three-Pronged Growth:** Strategy focuses on increasing the installed base in coding/marking, expanding co-packing revenue, and maturing new IP platforms to profitability before pursuing further M&A.